CDRI 82437

Drug Profile

CDRI 82437

Alternative Names: Compound 82437

Latest Information Update: 15 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Central Drug Research Institute
  • Class Anthelmintics; Benzimidazoles; Small molecules
  • Mechanism of Action Catalase inhibitors; Glutathione peroxidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Helminthiasis

Most Recent Events

  • 11 Sep 1995 No-Development-Reported for Helminthiasis in India (unspecified route)
  • 09 Dec 1994 Preclinical development for Helminthiasis in India (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top